In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EndyMed Ltd.

Latest From EndyMed Ltd.

Noninvasive Body Contouring Begins to Take Shape

This article first appeared in the December 2010 issue of Start-Up.

Start-Up Previews (12/2010)

A preview of the emerging health ncompanies profiled in the current issue of Start-Up. This month's profile group, "Noninvasive Body Contouring Begins To Take Shape," features profiles of EndyMed, Slender Medical and Zeltiq. Plus these Start-Ups Across Health Care: Auxogyn, Mucosis, NuVue Therapeutics, Taiga Biotechnologies and ZetrOZ.

EndyMed Ltd.

To stand out from the competition and attract the large potential market for fat reduction, companies must be able to show physicians and patients that a technology can provide a safe, noninvasive, no-downtime, pain-free and affordable procedure that produces noticeable body contouring effects. Israel-based EndyMed Ltd. believes its noninvasive skin tightening and face and body contouring technology will do exactly that. Its 3DEEP system is designed to overcome the problems caused by other types of RF devices.
Medical Device Platform Technologies

Noninvasive Body Contouring Begins To Take Shape

Noninvasive body contouring is the hottest new trend in aesthetics. The concept of losing fat without surgery is both appealing and promising to patients, aesthetic physicians, investors and medical device manufacturers alike, and industry has been quick to respond. In this issue, we profile three device start-ups that hope to gain footing in this lucrative market.
Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Medical Devices
    • Radiofrequency Devices
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • EndyMed Ltd.
  • Senior Management
  • Uzi Blumensohn, Pres. & CEO
    Mira Nesher, CFO
    Amy Kamin, SVP, North American Bus. Dev.
    Daniel Lischinsky, VP, R&D
  • Contact Info
  • EndyMed Ltd.
    Phone: (972) 4 630 9100
    North Industrial Zone
    7 Bareket St.